# 64Cu-DOTATATE-PET/CT in Neuroborreliosis Shows Increased Tracer Uptake in Dorsal Root and Paravertebral Ganglia

**Authors:** Mathilde Ørbæk, Marie Øbro Fosbøl, Anna Maria Florescu, Christian Midtgaard Stenør, Micha Phill Grønholm Jepsen, Jonathan Frederik Carlsen, Christian Thomas Brandt, Pelle Trier Petersen, Helene Mens, Åse Bengaard Andersen, Flemming Littrup Andersen, Ian Law, Annika Loft, Andreas Kjaer, Anne-Mette Lebech

PMC · DOI: 10.3390/diagnostics16040561 · 2026-02-13

## TL;DR

A PET/CT scan using 64Cu-DOTATATE shows increased uptake in nerve ganglia in patients with neuroborreliosis, possibly reflecting immune activity, but does not add diagnostic value beyond standard methods.

## Contribution

This study is the first to demonstrate symmetric 64Cu-DOTATATE uptake in dorsal root and paravertebral ganglia in neuroborreliosis patients.

## Key findings

- 10 out of 15 NB patients showed symmetric 64Cu-DOTATATE uptake in dorsal root and paravertebral ganglia.
- No controls showed lumbosacral ganglia uptake, suggesting specificity to NB.
- Only one patient had focal PET uptake matching MRI findings and clinical symptoms.

## Abstract

Background: Macrophages play a key role in clearing Borrelia burgdorferi infection and express somatostatin receptor subtype 2 (SSTR2), a potential imaging target. This study investigates immune activation in neuroborreliosis (NB) and assesses the diagnostic value of 64Cu-DOTATATE positron emission tomography/computed tomography (PET/CT) alongside magnetic resonance imaging (MRI). Methods: Prospective cohort study (2024–2025) enrolling patients with suspected NB from four Danish hospitals. NB was defined by the following ≥2 criteria: neurological symptoms, cerebrospinal fluid (CSF) pleocytosis, and intrathecal B. burgdorferi-specific antibodies; patients not meeting these criteria served as controls. Results: The study included 20 participants: 15 NB patients (75%) and 5 controls (25%). PET/CT was performed after a median of 9.5 days of antibiotic treatment. Symmetric 64Cu-DOTATATE uptake in dorsal root and paravertebral ganglia was observed in 10 of 15 patients, with cervical involvement in 8 and lumbosacral in 9. All of them had symptoms that corresponded to the anatomical distribution of the uptake. No controls had lumbosacral involvement (p = 0.04). One control with erythema migrans and systemic symptoms showed cervical ganglia uptake. MRI showed cranial or spinal nerve enhancement in five patients. Only one patient had focal PET uptake matching MRI findings and clinical facial palsy. Conclusions: Symmetric 64Cu-DOTATATE ganglionic uptake in NB patients may reflect immune activation or altered ganglionic physiology. One patient had focal 64Cu-DOTATATE uptake corresponding with palsy and MRI and 64Cu-DOTATATE PET/CT did not contribute additional diagnostic value beyond standard clinical evaluation.

## Linked entities

- **Chemicals:** 64Cu-DOTATATE (PubChem CID 124220636)
- **Diseases:** erythema migrans (MONDO:0007655)

## Full-text entities

- **Genes:** TSPO (translocator protein) [NCBI Gene 706] {aka BPBS, BZRP, DBI, IBP, MBR, PBR}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, SSTR2 (somatostatin receptor 2) [NCBI Gene 6752] {aka SST2}
- **Diseases:** infected (MESH:D007239), sarcoidosis (MESH:D012507), paresis (MESH:D010291), nerve involvement (MESH:C564676), dizziness (MESH:D004244), CSF pleocytosis (MESH:D007964), hypermetabolism (MESH:C565498), nerve-related symptoms (MESH:D012816), meningiomas (MESH:D008579), brain lesions (MESH:D001927), nerve damage (MESH:D000080902), erythema migrans (MESH:D005929), atherosclerotic plaques (MESH:D058226), Mental fatigue (MESH:D005222), facial palsy (MESH:D005158), Infectious Diseases (MESH:D003141), endocarditis (MESH:D004696), finger paresthesia (MESH:D010292), allergic reactions (MESH:D004342), muscle pain (MESH:D063806), reduced motivation (MESH:D001523), weakness (MESH:D018908), prosthetic valve (MESH:D006349), shoulder pain (MESH:D020069), sensory deficits (MESH:D012678), neuroinflammation (MESH:D000090862), Lyme arthritis (MESH:D008193), lymphocytic meningitis (MESH:D008580), inflammation (MESH:D007249), headaches (MESH:D006261), infected tick bite (MESH:D064927), injury to (MESH:D014947), neurodegeneration (MESH:D019636), cerebral hypometabolism (MESH:D002547), painful (MESH:D010146), peripheral nerve injury (MESH:D059348), skin lesions (MESH:D012871), polymyalgia rheumatica (MESH:D011111), neurological symptoms (MESH:D009461), NB (MESH:D020852), NETs (MESH:D018358), cranial nerve palsies (MESH:D003389), musculoskeletal pain (MESH:D059352), palsy (MESH:D010243), Fatigue (MESH:D005221)
- **Chemicals:** FDG (MESH:D019788), 18F-FDG (-), gadolinium (MESH:D005682), 68Ga-DOTATATE (MESH:C513399), 64Cu (MESH:C000615411), 64Cu-DOTATATE (MESH:C575629), DOTA (MESH:C071349)
- **Species:** Homo sapiens (human, species) [taxon 9606], Macaca mulatta (rhesus macaque, species) [taxon 9544], Mus musculus (house mouse, species) [taxon 10090], Borreliella burgdorferi (Lyme disease spirochete, species) [taxon 139]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939385/full.md

---
Source: https://tomesphere.com/paper/PMC12939385